Abstract: Biomaterial and scaffold development underpins the advancement of tissue engineering. Traditional scaffolds based on biodegradable polymers such as poly(lactic acid) and poly(lactic acidco-glycolic acid) are weak and non-osteoconductive. For bone tissue engineering, polymer-based composite scaffolds containing bioceramics such as hydroxyapatite can be produced and used. The bioceramics can be either incorporated in the scaffolds as a dispersed secondary phase or form a thin coating on the pore surface of polymer scaffolds. This bioceramic phase renders the scaffolds bioactive and also strengthens the scaffolds. There are a number of methods that can be used to produce bioceramic-polymer composite scaffolds. This paper gives an overview of our efforts in developing composite scaffolds for bone tissue engineering.
INTRODUCTION
Since the late 1980s, tissue engineering (TE) as a new discipline has made rapid advances [1] . Tissue engineering, as a potential medical treatment, holds promises of (a) eliminating re-operations by using biological substitutes, (b) using biological substitutes to solve problems of implant rejection, transmission of diseases associated with xenografts and allografts, and shortage in organ donation, (c) providing long-term solutions in tissue repair or treatment of diseases, and (d) potentially offering treatments for medical conditions that are currently untreatable. Tissue engineering has therefore attracted great attention in science, engineering, medicine, and the society [2] . It is now generally recognised that one of the key issues in tissue engineering is the development of suitable biodegradable materials and scaffolds for seeding cells and for the subsequent growth of tissues [3] . For bone tissue engineering, major issues of tissue engineering scaffolds include the use of appropriate matrix materials for scaffolds, control of porosity and pore characteristics of scaffolds, mechanical strength of scaffolds, scaffold degradation properties, and bioactivity (i.e., osteoconductivity, or osteoinductivity if possible) of scaffolds. Biomaterials experience with biodegradable polymers in the pre-TE time (before 1987 [4] ) has heavily guided researchers towards using medical-profession-accepted and the US Food and Drug Administration (FDA)-approved biopolymers such as poly(lactic acid) (PLA) and poly(lactic acid-co-glycolic acid) (PLGA) for constructing tissue engineering scaffolds. In recent years, other polymers have also been developed for tissue engineering applications [5] . Despite their phenomenal developments in the past three decades [6] , bioactive bioceramics (including glasses and glass-ceramics) have been overlooked for tissue engineering applications until recently. It has been shown that some bioactive glasses have the potential for bone tissue engineering [7] and there are now reports on the development of tissue engineering scaffolds purely made of bioceramics [8, 9] . Compared to the strengths of metals and ceramics for medical applications, the strengths of biodegradable polymers are already very low. With the introduction of pores in the polymers to form tissue engineering scaffolds, the strengths of porous structures are further decreased, as strengths of materials decrease drastically with an increase in porosity [10] . On the other hand, polymers such as PLA and poly(ε-caprolactone) (PCL) are considered to be non-osteoconductive. In order to seek better scaffolds for bone tissue engineering, a composite strategy can therefore be adopted [11] . Polymer-based scaffolds containing bioactive bioceramics can be produced in which the bioceramics can serve two purposes: (a) making the scaffolds osteoconductive, and (b) reinforcing the scaffolds. With this composite strategy, there are two approaches for making bioceramic-polymer composite scaffolds: (1) incorporating bioceramic particles in the scaffold through a variety of techniques; and (2) coating a polymer scaffold with a thin layer of apatite through biomimetic processes. Both strategies have been employed in our efforts to develop usable scaffolds for bone tissue engineering.
COMPOSITE SCAFFOLDS Particulate Bioceramics for Composite Scaffolds
Particulate materials of hydroxyapatite (HA), tricalcium phosphate (TCP) and a few bioactive glasses can be used in composite scaffolds for achieving osteoconductivity [11] . In one of our early investigations, plasma-sprayed HA (psHA) particles were produced and used, as particulate psHA was found to be more bioactive than highly crystalline HA particles due to the amorphous component in psHA particles [12] . These spherical psHA particles were in the micrometer size range (Fig.1a) . In our recent investigations, carbonated HA (CHA) particles were synthesized through a nanoemulsion process [13] . CHA is also more soluble and bioactive than highly crystalline HA due to the CO 3 2-substitution in HA lattice [6] . Furthermore, the spherical CHA particles were in the nanometer size range (Fig.1b) and are thus more suitable for incorporation into polymers to form composite scaffolds. 
Incorporating Bioceramic Particles in the Scaffolds
In our early investigations, psHA particles were incorporated in a poly(L-lactic acid) (PLLA) to form osteoconductive composite scaffolds [14] . The manufacturing process of these scaffolds is shown in Fig.2 . In this process, freeze-drying was used at the final stage to produce the porous structure. Just as in the production of polymer scaffolds [15] , for composite scaffolds, factors such as polymer solution concentration, porogen type and size, freeze-drying parameters, etc. play very important roles in forming the scaffolds of desired porous structures (pore geometry, pore size and size distribution, pore interconnectivity, thickness of pore walls, etc.) and hence the mechanical performance. It was shown through in vitro experiments that the composite scaffolds possessed bioactivity due to the incorporation of psHA particles (Fig.3) .
In a recent study, it was shown that using an emulsion freeze-drying process, composite scaffolds based on polyhydroxybutyrate (PHB) and polyhydroxybutyrate-co-valerate (PHBV) natural polymers could be produced [16] . In these scaffolds, the CHA nanospheres (Fig.1b) were incorporated. Through this process, highly porous structure with a controlled pore morphologies could be achieved (Fig.4) . In recent years, biodegradable fibers which have diameters in the nanometer range have attracted great attention, as it is considered that the proper in vivo phenotype cannot be consistently achieved if cells are presented with fibers with diameters equal to or greater than the cell size. Among technologies for making polymer fibers of nanometer dimensions, electrospinning is the most appealing and the process is relatively simple. A study was recently conducted on electrospinning of PHB and PHBV polymers and their composites [17] . It was found that electrospinning parameters (polymer solution concentration, solution feeding rate, injection needle diameter, electrical voltage, and working distance) all had significant effects on the resultant fibers. With careful experimentation, CHA/PHBV composite nanofibers containing CHA nanospheres could be produced (Fig.5) . The incorporation of CHA nanospheres was confirmed through EDX analyses of the fibers.
Rapid prototyping (RP) technologies have become increasingly popular for producing tissue engineering scaffolds, as there are a few distinctive advantages of using RP technologies. One of our efforts is to use the selective laser sintering (SLS) technology to manufacture CHA/PLA composite scaffolds [18] . In the SLS route, there are two major issues: (a) obtaining powders of appropriate characteristics for sintering, and (b) minimizing the use of sintering powder. The latter issue could be solved by building and installing a miniature sintering platform in a commercial SLS machine. The former issue required the production of composite powders of suitable characteristics. Through a microemulsion process, both PLA and CHA/PLA composite powders were made (Fig.6) . 
Coating the Polymer Scaffold with an Apatite Layer
As stated earlier, scaffolds made purely of biodegradable polymers such as PLA and PLGA are not osteoconductive. To impart bioactivity on the polymer scaffolds and also strengthen the scaffolds, apatite coatings could be formed on pores surfaces of the scaffolds before they are put in use for tissue engineering. For polymers, forming apatite coatings on their surfaces can be achieved through biomimetic processes. However, as polymers such as PLA degrades fast in the aqueous environment, normal biomimetic processes that have been developed for coating apatite on metals or ceramics [19] are not suitable for these polymers. Therefore, an accelerated biomimetic process was developed to coat PLLA scaffolds with a thin layer of apatite [20, 21] . Apatite was found to form on PGA meshes and PLLA scaffolds (Fig.7) , and with a dynamic environment, biomimetic apatite coatings could be produced on pores inside the scaffolds. Further investigations revealed that a composite coating consisting of nano-sized apatite crystals and collagen which mimics bone structure could also be produced on PLLA scaffolds (Fig.8) . It was found that the apatite coating and apatite/collagen composite coating could improve interactions between osteoblasts and PLLA scaffolds and that the composite coating was more effective than apatite coating in improving such interactions [22] . Fig.9 shows that osteoblast-like cells could attach and proliferate on the apatite/collagen coating formed on PLLA via the biomimetic process. 
CONCLUDING REMARKS
Currently, there are a number of strategies for developing bone tissue engineering scaffolds. The composite strategy provides a means for achieving stronger and bioactive scaffolds as compared to conventional polymer scaffolds. The two approaches in the composite route result in scaffolds of different, distinctive characteristics. Bioceramics obviously have an important role to play in constructing osteoconductive tissue engineering scaffolds. Systematic studies are required for the manufacture, characterisation, and in vitro and in vivo assessments of bioceramic-polymer composite scaffolds. Quite often, the scaffold manufacturing technology is selected together with considerations of choosing appropriate constituting materials of the composite. Osteoconductive composite scaffolds appear to have great potential for bone tissue engineering.
